Ask an Expert

Question of the Day

Eric J. Nestler, M.D., Ph.D. - Brain & behavior research expert on depression
September 11, 2013

Several rapidly acting antidepressants are currently in clinical trial, such as ketamine (see 2011 Highlights, Dr. Zarate, on p.2). These rapidly acting agents have novel mechanisms compared to currently available antidepressants and could offer significant improvement to patients who do not fully respond to today's medications. In addition, efforts continue to identify even more antidepressant medications with novel mechanisms of action.


Eric J. Nestler, M.D., Ph.D.
Scientific Council Member
Nash Family Professor of Neuroscience
Chair, Department of Neuroscience
Director, Friedman Brain Institute
Mount Sinai School of Medicine

Andrew A. Nierenberg, M.D. - brain & behavior research expert on bipolar disorder
Q Are there alternative treatments that might help people with mood disorders?
A Andrew A. Nierenberg, M.D., of Harvard Medical School received the Colvin... More >
Boris Birmaher, M.D. - brain & behavior research expert on bipolar disorder
Q Is Bipolar Disorder inheritable?
A Boris Birmaher, M.D., of the University of Pittsburgh School of Medicine... More >